Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Biotec Pharmacon (BIOTEC) NOK1

Sell:4.34 NOK Buy:4.40 NOK Change: 0.1 NOK (2.33%)
Market closed |  Prices as at close on 11 November 2019 | Switch to live prices |
Sell:4.34 NOK
Buy:4.40 NOK
Change: 0.1 NOK (2.33%)
Market closed |  Prices as at close on 11 November 2019 | Switch to live prices |
Sell:4.34 NOK
Buy:4.40 NOK
Change: 0.1 NOK (2.33%)
Market closed |  Prices as at close on 11 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biotec Pharmacon ASA is a Norway-based biopharmaceutical company that develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. The Company focuses on new solutions within wound care, cancer therapies and other immune related disease areas. It has a portfolio of patents covering marine gene products for the molecular biology sector, and products with potentials within the pharmaceutical sector, such as beta-1,3/1,6-glucan formulations. Biotec Pharmacon is the parent company of the group and controls two subsidiaries: ArcticZymes AS, which develops and supplies cold adapted and heat labile enzymes to international research reagents and diagnostic companies, and Biotec BetaGlucans AS, which handles all research and development, and manufacturing of beta-glucans within the group.

Contact details

Address:
Siva Innovasjonssenter, Sykehusvegen 23
TROMSO
9019
Norway
Telephone:
+47 (77) 648900
Website:
www.biotec.no/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BIOTEC
ISIN:
NO0010014632
Market cap:
207.36 million NOK
Shares in issue:
48.33 million
Sector:
Biotechnology
Exchange:
Oslo Stock Exchange
Country:
Norway
Currency:
Norwegian Krone
Indices:
Oslo All Share Index

Key personnel

  • Marie Roskrow
    Chairman of the Board
  • Jethro Holter
    Interim Chief Executive Officer, Managing Director of ArcticZymes AS
  • Borge Sorvoll
    Chief Financial Officer
  • Rolf Engstad
    Chief Scientific Officer
  • Finn Ketler
    Head of Wound Care Area

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.